No evidence for an association between the 5-hydroxytryptamine 5-HT2a receptor gene and schizophrenia in Kuwaiti Arabs

被引:13
作者
Haider, MZ
Zahid, MA
机构
[1] Kuwait Univ, Fac Med, Dept Pediat, Clin Genet Grp, Safat 13110, Kuwait
[2] Kuwait Univ, Fac Med, Dept Psychiat, Safat 13110, Kuwait
[3] Hosp Psychol Med, Kuwait, Kuwait
关键词
Kuwait; polymerase chain reaction; polymorphism; schizophrenia; serotonin;
D O I
10.1046/j.1440-1819.2002.01037.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The prevalence of T102C polymorphism of the 5-hydroxytryptamine 5-HT2a receptor gene has been investigated using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 80 Kuwaiti Arabs with schizophrenia and in 109 normal healthy controls with a similar ethnic background. There was no significant difference in the frequency of T102 polymorphism in the Kuwaiti cohort of schizophrenia patients and the controls (P = 0.23). The data from Kuwaiti Arabs (although our sample size is relatively small) support the findings from some other populations (Caucasians, Japanese), in which a lack of association has been found between T102C polymorphism and the onset of schizophrenia.
引用
收藏
页码:465 / 467
页数:3
相关论文
共 21 条
[1]  
ALAWADI SA, 1985, CLIN GENET, V27, P483
[2]   Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine [J].
Arranz, MJ ;
Munro, J ;
Owen, MJ ;
Spurlock, G ;
Sham, PC ;
Zhao, J ;
Kirov, G ;
Collier, DA ;
Kerwin, RW .
MOLECULAR PSYCHIATRY, 1998, 3 (01) :61-66
[3]   Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese [J].
Chen, CH ;
Lee, YR ;
Wei, FC ;
Koong, FJ ;
Hwu, HG ;
Hsiao, KJ .
PSYCHIATRIC GENETICS, 1997, 7 (01) :35-38
[4]  
Hawi Z, 1997, AM J MED GENET, V74, P370, DOI 10.1002/(SICI)1096-8628(19970725)74:4<370::AID-AJMG6>3.0.CO
[5]  
2-T
[6]  
He L, 1999, AM J MED GENET, V88, P95, DOI 10.1002/(SICI)1096-8628(19990205)88:1<95::AID-AJMG17>3.3.CO
[7]  
2-F
[8]  
Inayama Y, 1996, AM J MED GENET, V67, P103, DOI 10.1002/(SICI)1096-8628(19960216)67:1<103::AID-AJMG18>3.0.CO
[9]  
2-S
[10]  
Inayama Y, 1994, NEUROPSYCHOPHARMACOL, V10, P56